Fremanezumab is a monoclonal antibody medication used to treat migraine headaches, including chronic and episodic migraines. It is a type of CGRP receptor antagonist, which means that it blocks the receptor for calcitonin gene-related peptide (CGRP), a compound in the brain that is linked to inflammation and pain. Fremanezumab is administered as an injection given once every month or once every three months, depending on the dosage. It is typically given to people who have tried other migraine medications without success.
Fremanezumab, sold under the brand name Ajovy, is a medication specifically designed to help prevent migraines in adults. Here's a closer look at its characteristics:
Function:
- Migraine prevention: Fremanezumab works by targeting a molecule called calcitonin gene-related peptide (CGRP) which is thought to play a role in migraine headaches. By blocking CGRP, fremanezumab aims to reduce the frequency and severity of migraine attacks.
Administration:
- Injection: Fremanezumab is administered as a subcutaneous injection, meaning it's injected under the skin, typically in the thigh, abdomen, or upper arm.
- Dosing options:
- Monthly injections: One injection every month for ongoing prevention.
- Quarterly injections: Three injections given at once, followed by repeat injections every three months.
- A doctor will determine the most suitable dosing regimen based on individual needs.
Benefits:
- Can significantly reduce the number of migraine days experienced by individuals.
- May also help lessen the severity of migraine attacks.
Considerations:
- Not a cure: Fremanezumab works for prevention, not treatment of existing migraines.
- Potential side effects: The most common side effects are injection site reactions like pain, redness, or itching. Less frequent side effects include allergic reactions.
- Not for everyone: Fremanezumab is not recommended for pregnant or breastfeeding women, or those with a known hypersensitivity to the medication.
Overall:
Fremanezumab offers a promising option for adults struggling with frequent migraines. By consulting a healthcare professional, individuals can determine if fremanezumab is a suitable treatment approach for their specific situation.